European Green Transition




£6.45m Raised at IPO April 2024

AIM: EGT

Development. Innovation. Returns.

European Green Transition plc is a business operating in the green economy transition space in Europe. EGT intends to capitalise on the significant opportunity created by Europe’s transition away from fossil fuels to a green, renewables-focused economy.

EGT’s highly experienced leadership team have a strong track record of building successful public companies through the acquisition of distressed assets. EGT plans to replicate this approach, creating a sustainable and profitable business while generating significant shareholder returns.

The Company’s current portfolio of green economy assets includes the Olserum Rare Earth project in Sweden. The Olserum project is one of Sweden’s projects of “National Interest” and has the potential to become Europe’s first operating rare earths mine. EGT own additional projects in northern Sweden and Germany which have defined and tangible upside with potential to realise near-term value inflection points in a cost effective manner. EGT’s objective is to build a profitable business while monetising some of its assets through sale or partnership with larger industry players or European end users. The team is focused on success while remaining committed to its defined ESG strategy, ensuring excellent development practices across all projects in addition to regular local community engagement.

At Raglan Capital we recognise that the future is green energy; as global focus shifts to more sustainable living, the green energy sector will continue to grow exponentially and European Green Transition aims to capitalise on the generational opportunity created by the rapidly accelerating green energy transition in Europe.
— Cathal Friel

Our Other IPO Companies

Poolbeg Pharma plc

  • Spun out of Open Orphan & listed on AIM in July 2021. Commenced trading on OTCQB in the US in March 2022.

hVIVO plc

  • Listed on AIM and Euronext in June 2019 through the reverse takeover of Venn Life Sciences plc and acquired hVIVO plc in January 2020.

Amryt Pharma plc

  • Listed on AIM and Euronext in 2016, raising £20m in funding. Listed on Nasdaq in 2020 and was sold for $1.48bn in 2023.

Fastnet Oil & Gas plc

  • Raised over $50m through its floatation on the London and Dublin stock exchanges.